News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,991 Results
Type
Article (55547)
Company Profile (115)
Press Release (539329)
Section
Business (177326)
Career Advice (1975)
Deals (31368)
Drug Delivery (78)
Drug Development (64840)
Employer Resources (135)
FDA (14736)
Job Trends (12488)
News (294493)
Policy (26512)
Tag
Academia (2672)
Alliances (46418)
Alzheimer's disease (1144)
Approvals (14693)
Artificial intelligence (117)
Bankruptcy (263)
Best Places to Work (9776)
Biotechnology (76)
Breast cancer (89)
Cancer (929)
Cardiovascular disease (80)
Career advice (1632)
Cell therapy (192)
Clinical research (50739)
Collaboration (363)
Compensation (82)
COVID-19 (2196)
C-suite (87)
Data (943)
Diabetes (135)
Diagnostics (5550)
Earnings (70810)
Employer resources (112)
Events (76342)
Executive appointments (288)
FDA (15214)
Funding (330)
Gene therapy (149)
GLP-1 (579)
Government (3268)
Healthcare (15685)
Infectious disease (2270)
Inflammatory bowel disease (93)
Interviews (361)
IPO (14490)
Job creations (3005)
Job search strategy (1392)
Layoffs (339)
Legal (5760)
Lung cancer (145)
Manufacturing (162)
Medical device (11725)
Medtech (11730)
Mergers & acquisitions (16997)
Metabolic disorders (385)
Neuroscience (1388)
NextGen Class of 2024 (5306)
Non-profit (3995)
Northern California (1171)
Obesity (223)
Opinion (185)
Patents (87)
People (48539)
Phase I (15076)
Phase II (21822)
Phase III (17558)
Pipeline (443)
Postmarket research (2344)
Preclinical (7515)
Radiopharmaceuticals (199)
Rare diseases (187)
Real estate (5321)
Regulatory (18609)
Research institute (2551)
Resumes & cover letters (312)
Southern California (1005)
Startups (3073)
United States (10690)
Vaccines (496)
Weight loss (175)
Date
Today (114)
Last 7 days (684)
Last 30 days (3228)
Last 365 days (30166)
2024 (27680)
2023 (34151)
2022 (44576)
2021 (48201)
2020 (46438)
2019 (40044)
2018 (30479)
2017 (29492)
2016 (28583)
2015 (34226)
2014 (26771)
2013 (23384)
2012 (24239)
2011 (25034)
2010 (23187)
Location
Africa (740)
Arizona (118)
Asia (40721)
Australia (6892)
California (2548)
Canada (1083)
China (231)
Colorado (123)
Connecticut (124)
Europe (84470)
Florida (400)
Georgia (110)
Illinois (272)
Indiana (152)
Kansas (81)
Maryland (451)
Massachusetts (1823)
Michigan (147)
Minnesota (213)
New Jersey (854)
New York (823)
North Carolina (615)
Northern California (1171)
Ohio (122)
Pennsylvania (640)
South America (1061)
Southern California (1005)
Texas (384)
Utah (74)
Washington State (308)
594,991 Results for "transparency market research pvt ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer Stem Cells Market to Reach USD 4.5 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.
May 17, 2024
·
1 min read
Press Releases
BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD.
October 7, 2024
·
5 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
BioMidwest
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University
Rafarma Pharmaceuticals - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023.
December 11, 2023
·
3 min read
Business
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano has entered into a software marketing agreement with Revvity, Inc. (Revvity) under which Revvity will market and commercialize Bionano’s VIA™ software to Revvity’s next generation sequencing (NGS) customers as part of its newborn sequencing research workflow.
June 20, 2024
·
5 min read
Business
ValGenesis and Life Science Consulting Pvt. Ltd. Form Partnership to Enhance Quality and Compliance for Life Sciences Companies Across North America, Europe, and Asia
ValGenesis, Inc. and Life Science Consulting Pvt. Ltd. have partnered to provide best-in-class digital validation solutions to enhance compliance and quality across life sciences disciplines such as production, quality control and assurance, information technology, and research and development.
May 30, 2023
·
3 min read
Career Advice
How to Negotiate Your Salary According to Market Value
In our comprehensive guide to salary negotiation, we’ll teach you what a market salary is, how to research a market value salary and, ultimately, how to negotiate your salary according to market value.
October 1, 2024
·
5 min read
·
Franklin Carpenter
Press Releases
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
October 28, 2024
·
6 min read
Deals
Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two letters from the listing qualifications department staff of The Nasdaq Stock Market.
March 15, 2024
·
5 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
1 of 59,500
Next
